Park National (PRK) Stock: Buy, Sell, or Hold?
$178.86
-0.96 (-0.53%)
âŧ
5d:
-2.11%
30d:
+1.84%
90d:
-13.85%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (70%)
Quality Score
49/100
Position
FAIR
30-Day Fair Range
$176.78 â $181.77
Position: FAIR
Forward P/E & Valuation
13.6x
FAIR
vs 14.0x historical avg
Wall Street Target
$199.50
+11.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$170.54 / $186.55
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: PRK is fairly priced but lacks strong directional signals. At -0.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Get Alerted When PRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$358.24
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$222.44
19.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRK is currently trading at $178.86, which is considered fair relative to its 30-day fair value range of $176.78 to $181.77. The stock's valuation (Forward PE: 13.6) is in line with its historical norms (14.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This pessimistic expectation contrasts with the company's recent 7.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PRK is in a downtrend. Immediate support is located at $170.54, while resistance sits at $186.55.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $199.50 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRK is in a downtrend. Immediate support is located at $170.54, while resistance sits at $186.55.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $199.50 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$176.78 -
$181.77
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
Trading Range & Key Levels
30-Day Trading Range
$176.78 -
$181.77
Current vs Trading Range
FAIR
Support Level
$170.54
Resistance Level
$186.55
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($199.50)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
13.61
Wall Street Target
$199.50
(+11.5%)
Revenue Growth (YoY)
29.6%
Earnings Growth (YoY)
7.2%
Profit Margin
30.8%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
13.6 vs 14.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$177.25
(-1%)
2-Year Target
$175.66
(-2%)
3-Year Target
$174.07
(-3%)
3-Yr Target (if PE normalizes)
(PE: 14â14)
$179.04
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 99.9%)
$268.86
(+50%)
Base:
(SPY PE: 13.6, Growth: 99.9%)
$184.28
(+3%)
Bear:
(PE: 11.6, Growth: 99.9%)
$156.63
(-12%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 15.72 | Current EPS (TTM): $11.44
Bull Case
$227.20
(+27%)
Analyst growth 14.9%, PE expands to 17.3
Base Case
$206.54
(+16%)
Market implied 14.9%, PE stable at 15.7
Bear Case
$122.28
(-32%)
Severe decline -20.0%, PE contracts to 13.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.6 to 14.0
Stabilization Target:
$183.96
(+2.9%)
PE Expansion Potential:
+2.9%
Share PRK Analysis
Share this live PRK analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 12, 2026 4:45 AM ET
Data refreshes hourly during market hours. Next update: 5:45 AM
Data refreshes hourly during market hours. Next update: 5:45 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Banks - Regional Stocks
Top-rated stocks in Banks - Regional by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NU
Nu Holdings Ltd |
STRONG BUY
23 analysts |
$19 | 71 BUY |
|
FITB
Fifth Third Bancorp |
STRONG BUY
22 analysts |
$62 | 54 HOLD |
|
KEY
KeyCorp |
BUY
20 analysts |
$25 | 54 HOLD |
|
EWBC
East West Bancorp Inc |
STRONG BUY
16 analysts |
$152 | 44 HOLD |
|
UMBF
UMB Financial Corporation |
STRONG BUY
16 analysts |
$161 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PRK Research Pages